Key statistics
As of last trade Dexcom Inc (DC4:BRN) traded at 59.53, 4.93% above its 52-week low of 56.73, set on Sep 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 59.53 |
---|---|
High | 59.53 |
Low | 59.53 |
Bid | 59.41 |
Offer | 59.54 |
Previous close | 59.53 |
Average volume | -- |
---|---|
Shares outstanding | 390.60m |
Free float | 389.35m |
P/E (TTM) | 45.45 |
Market cap | 29.08bn USD |
EPS (TTM) | 1.64 USD |
Data delayed at least 15 minutes, as of Nov 07 2024.
More ▼
Press releases
- Dexcom and ŌURA Announce Strategic Partnership
- Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
- Dexcom Reports Third Quarter 2024 Financial Results
- Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
- Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
- Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
- Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
- Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
- Dexcom Announces Upcoming Conference Presentation
- Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
More ▼